Showing results (2331-2340 of 19,560) with videos related to
Sort By:
Pageof 1,956
BMC Cancer|October 14, 2016
Successful treatment of gemcitabine-induced acute interstitial pneumonia with imatinib mesylate: a case reportElisabetta Fenocchio, Ilaria Depetris, Delia Campanella, et al.BMC Cancer|April 30, 2014
Gastric Helicobacter pylori infection associates with an increased risk of colorectal polyps in African AmericansHassan Brim, Marwah Zahaf, Adeyinka O Laiyemo, et al.BMC Cancer|October 1, 2016
Role of autophagy and lysosomal drug sequestration in acquired resistance to doxorubicin in MCF-7 cellsBaoqing Guo, Adam Tam, Stacey A Santi, et al.BMC Cancer|January 31, 2014
Cellular immunotherapy using irradiated lung cancer cell vaccine co-expressing GM-CSF and IL-18 can induce significant antitumor effectsHongwei Tian, Gang Shi, Guoyou Yang, et al.BMC Cancer|March 23, 2017
Uniform FDG-PET guided GRAdient Dose prEscription to reduce late Radiation Toxicity (UPGRADE-RT): study protocol for a randomized clinical trial with dose reduction to the elective neck in head and neck squamous cell carcinomaSven van den Bosch, Tim Dijkema, Martina C Kunze-Busch, et al.BMC Cancer|March 24, 2017
Tumor burden monitoring using cell-free tumor DNA could be limited by tumor heterogeneity in advanced breast cancer and should be evaluated together with radiographic imagingJosé Angel García-Saenz, Patricia Ayllón, Marion Laig, et al.BMC Cancer|March 26, 2017
u-PAR expression in cancer associated fibroblast: new acquisitions in multiple myeloma progressionS Ciavarella, A Laurenzana, S De Summa, et al.BMC Cancer|November 23, 2012
Phase I study of TP300 in patients with advanced solid tumors with pharmacokinetic, pharmacogenetic and pharmacodynamic analysesD Alan Anthoney, Jay Naik, Iain R J Macpherson, et al.BMC Cancer|November 23, 2012
PTPRZ1 regulates calmodulin phosphorylation and tumor progression in small-cell lung carcinomaHideki Makinoshima, Genichiro Ishii, Motohiro Kojima, et al.BMC Cancer|November 23, 2012
The downregulation of Mcl-1 via USP9X inhibition sensitizes solid tumors to Bcl-xl inhibitionChander Peddaboina, Daniel Jupiter, Steven Fletcher, et al.Pageof 1,956